Structural, Genetic, and Serological Elucidation of Streptococcus pneumoniae Serogroup 24 Serotypes: Discovery of a New Serotype, 24C, with a Variable Capsule Structure
- PMID: 33883183
- PMCID: PMC8218768
- DOI: 10.1128/JCM.00540-21
Structural, Genetic, and Serological Elucidation of Streptococcus pneumoniae Serogroup 24 Serotypes: Discovery of a New Serotype, 24C, with a Variable Capsule Structure
Abstract
Pneumococcal capsules are important in pneumococcal pathogenesis and vaccine development. Although conjugate vaccines have brought about a significant reduction in invasive pneumococcal disease (IPD) caused by vaccine serotypes, the relative serotype prevalence has shifted with the dramatic emergence of serotype 24F in some countries. Here, we describe 14 isolates (13 IPD and 1 non-IPD) expressing a new capsule type, 24C, which resembles 24F but has a novel serological profile. We also describe the antigenic, biochemical, and genetic basis of 24F and 24C and the related serotypes 24A and 24B. Structural studies show that 24B, 24C, and 24F have identical polysaccharide backbones [β-Ribf-(1→4)-α-Rhap-(1→3)-β-GlcpNAc-(1→4)-β-Rhap-(1→4)-β-Glcp] but with different side chains, as follows: 24F has arabinitol-phosphate and 24B has ribitol-phosphate. 24C has a mixture of 24F and 24B repeating units, with the ratio of ribitol to arabinitol being strain dependent. In contrast, the 24A capsule has a backbone without β-Ribf but with arabinitol-phosphate and phosphocholine side chains. These structures indicate that factor-sera 24d and 24e recognize arabinitol and ribitol, respectively, which explains the serology of serogroup 24, including those of 24C. The structures can be genetically described by the bispecificity of wcxG, which is capable of transferring arabinitol or ribitol when arabinitol is limiting. Arabinitol is likely not produced in 24B but is produced in reduced amounts in 24C due to various mutations in abpA or abpB genes. Our findings demonstrate how pneumococci modulate their capsule structure and immunologic properties with small genetic changes, thereby evading host immune responses. Our findings also suggest a potential for new capsule types within serogroup 24.
Keywords: Streptococcus pneumoniae; capsule polysaccharide; genetic heterogeneity; serogroup; vaccine.
Figures





Similar articles
-
Evaluation of GC-MS for identification and characterization of pneumococcal serotype 24A, 24B, and 24F capsular polysaccharide.Biochem Biophys Res Commun. 2024 Oct 15;729:150356. doi: 10.1016/j.bbrc.2024.150356. Epub 2024 Jul 6. Biochem Biophys Res Commun. 2024. PMID: 38986261
-
New pneumococcal serotype 20C is a WciG O-acetyltransferase deficient variant of canonical serotype 20B.Microbiol Spectr. 2025 Jan 7;13(1):e0244324. doi: 10.1128/spectrum.02443-24. Epub 2024 Nov 29. Microbiol Spectr. 2025. PMID: 39612217 Free PMC article.
-
Increase in prevalence of Streptococcus pneumoniae serogroup 24 in children upon introducing 13-valent pneumococcal conjugate vaccine in Japan.Access Microbiol. 2023 Mar 15;5(3):acmi000507.v3. doi: 10.1099/acmi.0.000507.v3. eCollection 2023. Access Microbiol. 2023. PMID: 37091738 Free PMC article.
-
CIRCULATING CLONAL COMPLEXES AND SEQUENCE TYPES OF STREPTOCOCCUS PNEUMONIAE SEROTYPE 19A WORLDWIDE: THE IMPORTANCE OF MULTIDRUG RESISTANCE: A SYSTEMATIC LITERATURE REVIEW.Expert Rev Vaccines. 2021 Jan;20(1):45-57. doi: 10.1080/14760584.2021.1873136. Epub 2021 Feb 17. Expert Rev Vaccines. 2021. PMID: 33507135
-
The relative invasive disease potential of Streptococcus pneumoniae among children after PCV introduction: A systematic review and meta-analysis.J Infect. 2018 Nov;77(5):368-378. doi: 10.1016/j.jinf.2018.06.004. Epub 2018 Jun 30. J Infect. 2018. PMID: 29964140
Cited by
-
Measuring Niche-Associated Metabolic Activity in Planktonic and Biofilm Bacteria.Methods Mol Biol. 2023;2674:3-32. doi: 10.1007/978-1-0716-3243-7_1. Methods Mol Biol. 2023. PMID: 37258957
-
Rewiring the pneumococcal capsule pathway for investigating glycosyltransferase specificity and genetic glycoengineering.Sci Adv. 2023 Sep 8;9(36):eadi8157. doi: 10.1126/sciadv.adi8157. Epub 2023 Sep 6. Sci Adv. 2023. PMID: 37672581 Free PMC article.
-
Fourier transform infrared spectroscopy for Streptococcus pneumoniae capsular serotype classification in pediatric patients with invasive infections.Front Microbiol. 2024 Nov 21;15:1497377. doi: 10.3389/fmicb.2024.1497377. eCollection 2024. Front Microbiol. 2024. PMID: 39640858 Free PMC article.
-
Changes in pneumococcal serotypes distribution and penicillin resistance in healthy children five years after generalization of PCV10.Heliyon. 2024 Feb 9;10(4):e25741. doi: 10.1016/j.heliyon.2024.e25741. eCollection 2024 Feb 29. Heliyon. 2024. PMID: 38380016 Free PMC article.
-
Peptide linker increased the stability of pneumococcal fusion protein vaccine candidate.Front Bioeng Biotechnol. 2023 Jan 26;11:1108300. doi: 10.3389/fbioe.2023.1108300. eCollection 2023. Front Bioeng Biotechnol. 2023. PMID: 36777254 Free PMC article.
References
-
- Siber GR, Thompson C, Reid GR, Almeido-Hill J, Zacher B, Wolff M, Santosham M. 1992. Evaluation of bacterial polysaccharide immune globulin for the treatment or prevention of Haemophilus influenzae type b and pneumococcal disease. J Infect Dis 165:S129–S133. 10.1093/infdis/165-supplement_1-s129. - DOI - PubMed
-
- Andrews NJ, Waight PA, Burbidge P, Pearce E, Roalfe L, Zancolli M, Slack M, Ladhani SN, Miller E, Goldblatt D. 2014. Serotype-specific effectiveness and correlates of protection for the 13-valent pneumococcal conjugate vaccine: a postlicensure indirect cohort study. Lancet Infect Dis 14:839–846. 10.1016/S1473-3099(14)70822-9. - DOI - PubMed
-
- Croucher NJ, Harris SR, Fraser C, Quail MA, Burton J, van der Linden M, McGee L, von Gottberg A, Song JH, Ko KS, Pichon B, Baker S, Parry CM, Lambertsen LM, Shahinas D, Pillai DR, Mitchell TJ, Dougan G, Tomasz A, Klugman KP, Parkhill J, Hanage WP, Bentley SD. 2011. Rapid pneumococcal evolution in response to clinical interventions. Science 331:430–434. 10.1126/science.1198545. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical